CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 87 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 197 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 197 | -25.7% | 0.00% | – |
| Q4 2017 | $7,000 | +600.0% | 265 | +86.6% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -98.1% | 142 | -98.1% | 0.00% | -100.0% |
| Q1 2016 | $103,000 | -28.0% | 7,532 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $143,000 | -3.4% | 7,532 | -4.7% | 0.00% | 0.0% |
| Q3 2015 | $148,000 | +1245.5% | 7,905 | +1013.4% | 0.00% | – |
| Q2 2015 | $11,000 | – | 710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |